2020 Volume 29 Issue 12 Pages 845-851
Recently, recommendations of managing cerebral arteriovenous malformations (AVMs) with multimodal treatment in conjunction with the completion of the ARUBA study have significantly reduced the number of direct surgeries for AVMs. Nevertheless, favorable safety profiles and cure rates can still be achieved with appropriate patient selection and judicious use of intraoperative support devices. In this article, we present our experience in the direct surgery of AVMs in the present setting, and discuss the central role of surgery to promote treatment outcomes. In addition, it is important to utilize practice-based data to establish indication criteria that reflects surgical outcomes.